Antibiotic susceptibility and characteristics of neisseria meningitidis isolates from the African Meningitis belt, 2000 to 2006: Phenotypic and genotypic perspectives

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1561-1566

  Hedberg, Sara Thulin ^a   Fredlund, Hans ^a   Nicolas, Pierre ^b   Caugant, Dominique A ^c   Olcén, Per ^a   Unemo, Magnus ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN G; PENICILLIN V; RIFAMPICIN; SULFADIAZINE; TETRACYCLINE;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD GROUP TYPING; EPSILOMETER TEST; GENE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PENA GENE; PHENOTYPE; PRIORITY JOURNAL;

AFRICA; GENOTYPE; HUMANS; MENINGITIS, MENINGOCOCCAL; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; PHENOTYPE; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

EID: 65649108627     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00994-08     Document Type: Article

References (45)

1. Alcalá, B., C. Salcedo, L. de la Fuente, L. Arreaza, M. J. Uría, R. Abad, R. Enríquez, J. A. Vázquez, M. Motgé, and J. de Batlle. 2004. Neisseria menin-gitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. J. Antimicrob. Chemother. 53:409. (Pubitemid 38239990)
2. Antignac, A., M. Ducos-Galand, A. Guiyoule, R. Pires, J. M. Alonso, and M. K. Taha. 2003. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin. Infect. Dis. 37:912-920. (Pubitemid 37267205)
3. Antignac, A., P. Kriz, G. Tzanakaki, J. M. Alonso, and M. K. Taha. 2001. Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. J. Antimicrob. Chemother. 47:285-296. (Pubitemid 32229570)
4. Arreaza, L., and J. A. Vázquez. 2001. Molecular approach for the study of penicillin resistance in Neisseria meningitidis, p. 107-119. In A.Z. Pollard and M. C. J. Maiden (ed.), Meningococcal disease: methods and protocols. Humana Press, Totowa, NJ.
5. British Society for Antimicrobial Chemotherapy. February 2008. BSAC methods for antimicrobial susceptibility testing, version 7.1. BSAC, Birmingham, United Kingdom.
6. Caugant, D. A., and P. Nicolas. 2007. Molecular surveillance of meningococcal meningitis in Africa. Vaccine 25(Suppl.1):A8-A11. (Pubitemid 47208590)
7. Centers for Disease Control and Prevention (CDC). 2008. Emergence of fluoroquinolone-resistant Neisseria meningitidis-Minnesota and North Dakota, 2007-2008. MMWR Morb. Mortal. WkIy. Rep. 57:173-175. (Pubitemid 350293413)
8. Chu, Y. W., T. K. Cheung, V. Tung, F. Tiu, J. Lo, R. Lam, R. Lai, and K. K. Wong. 2007. A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong. Int. J. Antimicrob. Agents 30:94-95. (Pubitemid 46874892)
9. Corso, A., D. Faccone, M. Miranda, M. Rodriguez, M. Regueira, C. Carranza, C. Vencina, J. A. Vázquez, and M. Galas. 2005. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J. Antimicrob. Chemother. 55:596-597. (Pubitemid 40542610)
10. Crawford, S. A., K. R. Fiebelkorn, J. E. Patterson, and J. H. Jorgensen. 2005. International clone of Neisseria meningitidis serogroup A with tetracycline resistance due to Wi(B). Antimicrob. Agents Chemother. 49:1198-1200. (Pubitemid 40327747)
11. du Plessis, M., A. von Gottberg, C. Cohen, L. de Gouveia, and K. P. Klugman. 2008. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol.46:3208-3214.
12. Gagneux, S., A. Hodgson, I. Ehrhard, G. Morelli, B. Genton, T. Smith, M. Tanner, F. Binka, M. Achtman, and G. Pluschke. 2000. Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Trop. Med. Int. Health 5:280-287. (Pubitemid 30316802)
13. Galimand, M., G. Gerbaud, M. Guibourdenche, J. Y. Riou, and P. Courvalin. 1998. High-level chloramphenicol resistance in Neisseria meningitidis. N. Engl. J. Med. 339:868-874. (Pubitemid 28446844)
14. Greenwood, B. 2006. Editorial: 100 years of epidemic meningitis in West Africa-has anything changed? Trop. Med. Int. Health 11:773-780. (Pubitemid 43846435)
15. Greenwood, B. 1999. Manson lecture. Meningococcal meningitis in Africa. Trans. R. Soc. Trop. Med. Hyg. 93:341-353. (Pubitemid 30214832)
16. Jacobsson, S., M. Issa, M. Unemo, A. Bäckman, P. Moiling, N. Sulaiman, and P. Oleen. 2003. Molecular characterisation of group A Neisseria meningitidis isolated in Sudan 1985-2001. APMIS 111:1060-1066. (Pubitemid 37521899)
17. Jorgensen, J. H., S. A. Crawford, and K. R. Fiebelkorn. 2005. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J. Clin. Microbiol. 43:3162-3171. (Pubitemid 40981318)
18. Maiden, M. C, J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:3140-3145. (Pubitemid 28135868)
19. Manchanda, V., and P. Bhalla. 2006. Emergence of non-ceftriaxone- susceptible Neisseria meningitidis in India. J. Clin. Microbiol. 44:4290-4291.
20. Moiling, P., S. Jacobsson, A. Backman, and P. Oleen. 2002. Direct and rapid identification and genogrouping of meningococci zndporA amplification by LightCycler PCR. J. Clin. Microbiol. 40:4531-4535. (Pubitemid 35434942)
21. Nicolas, P., V. Manchanda, and P. Bhalla. 2007. Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India. J. Clin. Microbiol. 45:1378. (Pubitemid 46626525)
22. Nicolas, P., G. Norheim, E. Garnotel, S. Djibo, and D. A. Caugant. 2005. Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-Il complexes. J. Clin. Microbiol. 43:5129-5135. (Pubitemid 41484016)
23. Oppenheim, B. A. 1997. Antibiotic resistance in Neisseria meningitidis. Clin. Infect. Dis. 24(Suppl. 1):S98-S101. (Pubitemid 27024352)
24. Rainbow, J., E. Cebelinski, J. Bartkus, A. Glennen, D. Boxrud, and R. Lynfleld. 2005. Rifampin-resistant meningococcal disease. Emerg. Infect. Dis. 11:977-979. (Pubitemid 40720871)
25. Scarborough, M., S. B. Gordon, C. J. Whitty, N. French, Y. Njalale, A. Chitani, T. E. Peto, D. G. Lalloo, and E. E. Zfjlstra. 2007. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N. Engl. J. Med. 357:2441-2450. (Pubitemid 350272783)
26. Shultz, T. R., J. W. Tapsall, P. A. White, C. S. Ryan, D. Lyras, J. I. Rood, E. Binotto, and C. J. Richardson. 2003. Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia. J. Antimicrob. Chemother. 52:856-859. (Pubitemid 37407817)
27. Skoczynska, A., J. M. Alonso, and M. K. Taha. 2008. Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg. Infect. Dis. 14:1322-1323.
28. Spratt, B. G. 1994. Resistance to antibiotics mediated by target alterations. Science 264:388-393. (Pubitemid 24986723)
29. Stefanelli, P., A. Carattoli, A. Neri, C. Fazio, and P. Mastrantonio. 2003. Prediction of decreased susceptibility to penicillin of Neisseria meningitidis strains by real-time PCR. J. Clin. Microbiol. 41:4666-4670. (Pubitemid 37259774)
30. Stefanelli, P., C. Fazio, G. La Rosa, C. Marianelli, M. Musculo, and P. Mastrantonio. 2001. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J. Antimicrob. Chemother. 47:219-222. (Pubitemid 32149533)
31. Stephens, D. S., B. Greenwood, and P. Brandtzaeg. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196-2210. (Pubitemid 46977462)
32. Strahilevitz, J., A. Adler, G. Smollan, V. Temper, N. Keller, and C. Block. 2008. Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin. Emerg. Infect. Dis. 14:1667-1669. (Pubitemid 350293468)
33. Taha, M. K., J. A. Vazquez, E. Hong, D. E. Bennett, S. Bertrand, S. Bukovski, M. T. Cafferkey, F. Carion, J. J. Christensen, M. Diggle, G. Edwards, R. Enriquez, C. Fazio, M. Frosch, S. Heubei-ger, S. Hoffmann, K. A. Jolley, M. Kadlubowski, A. Kechrid, K. Kesanopoulos, P. Kriz, L. Lambertsen, I. Levenet, M. Musilek, M. Paragi, A. Saguer, A. Skoczynska, P. Stefanelli, S. Thulin, G. Tzanakaki, M. Unemo, U. Vogel, and M. L. Zarantonelli. 2007. Target gene sequencing to characterize the penicillin G susceptibility of Nässeria meningitidis. Antimicrob. Agents Chemother. 51:2784-2792. (Pubitemid 47206213)
34. Taha, M. K., M. L. Zarantonelli, C. Ruckly, D. Giorgini, and J. M. Alonso. 2006. Rifampin-resistant Neisseria meningitidis. Emerg. Infect. Dis. 12:859-860. (Pubitemid 43726872)
35. Teyssou, R., and E. Muros-Le Rouzic. 2007. Meningitis epidemics in Africa: a brief overview. Vaccine 25(Suppl. 1):A3-A7. (Pubitemid 47198925)
36. Thulin, S., P. Oleen, H. Fredlund, and M. Unemo. 2006. Total variation in the penA gene oí Neisseria meningitidis: correlation between susceptibility to ß-lactam antibiotics and penA gene heterogeneity. Antimicrob. Agents Chemother. 50:3317-3324. (Pubitemid 44527504)
37. Tondella, M. L., N. E. Rosenstein, L. W. Mayer, F. C. Tenover, S. A. Stocker, M. W. Reeves, and T. Popovic. 2001. Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa. Emerg. Infect. Dis. 7:163-164. (Pubitemid 32173353)
38. Unemo, M., P. Oleen, J. Albert, and H. Fredlund. 2003. Comparison of serologic and genetic po;-S-based typing of Neisseria gonorrhoeae: consequences for future characterization. J. Clin. Microbiol. 41:4141-4147. (Pubitemid 37099677)
39. Van de Peer, Y., and R. De Wächter. 1994. TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput. Appl. Biosci. 10:569-570.
40. Vázquez, J. A. 2001. The resistance oí Nässeria meningitidis to the antimicrobial agents: an issue still in evolution. Rev. Med. Microbiol. 12:39-45. (Pubitemid 32095754)
41. Vázquez, J. A. 2007. Resistance testing of meningococci: the recommendations of the European Monitoring Group on Meningococci. FEMS Microbiol. Rev. 31:97-100. (Pubitemid 46058825)
42. Vázquez, J. A., L. Arreaza, C. Block, I. Ehrhard, S. J. Gray, S. Heuberger, S. Hoffmann, P. Kriz, P. Nicolas, P. Oleen, A. Skoczynska, L. Spanjaard, P. Stefanelli, M. K. Taha, and G. Tzanakaki. 2003. Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management oiNeisseria meningitidis infections. Antimicrob. Agents Chemother. 47:3430-3434. (Pubitemid 37345700)
43. Vázquez, J. A., R. Enriquez, R. Abad, B. Alcalá, C. Salcedo, and L. Arreaza. 2007. Antibiotic resistant meningococci in Europe: any need to act? FEMS Microbiol. Rev. 31:64-70. (Pubitemid 46058821)
44. World Health Organization. 2007. Standardized treatment of bacterial meningitidis in Africa in epidemic and non epidemic situations. Epidemic and pandemic alert and response 3. World Health Organization, Geneva, Switzerland.
45. Zerouali, K., N. Elmdaghri, M. Boudouma, and M. Benbachir. 2002. Serogroups, serotypes, serosubtypes and antimicrobial susceptibility oiNeisseria meningitidis isolates in Casablanca, Morocco. Eur. J. Clin. Microbiol. Infect. Dis. 21:483-485. (Pubitemid 34756928)